Top NIH Funding News

Important news from NIH for all grantees.

• Budget update: The U.S. federal government, including Fogarty and all of the NIH, is funded through Sept. 2020. Further Consolidated Appropriations Act, 2020 (H.R.1865) was passed by Congress and signed by President Trump on Dec. 20, 2019. Access information about appropriations for fiscal year 2020 from Congress.gov.

• OMB Approval for Grant Application and Related Forms Underway Continue to Use Current Forms (FORMS-E) through May 24, 2020 (NOT-OD-20-047)
  For due dates on or before May 24, 2020, applicants must continue to use the application form packages and instructions (FORMS-E) posted with our funding opportunity announcements despite the expiration dates noted on each form. These forms are extended for use through March 2020.

Funding Opportunities

NIH requests and funding opportunities focusing on global health and foreign collaboration.

• Learning from the Transfer of HIV Interventions from Low- and Middle-Income Countries (LMICs) to the United States: Informing the Plan for America to End the HIV Epidemic (NOT-TW-19-008)
  To support Ending the HIV Epidemic: A Plan for America, NIH is seeking additional information about HIV interventions developed in LMICs that could or should be transferred to the U.S. specifically to address the HIV high burden areas. Submit responses by February 15, 2020.

• Notice of Special Interest: Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-20-038)
  Fogarty is interested in research on ethical issues relevant to low- and middle-income countries, in particular, studies conducted by investigators in these countries.
  Application Due Date: March 1, 2020

• Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars (NOT-OD-20-054)
  NIH Mentored Career Development (K) Award Recipients and Scholars can apply to receive administrative supplements to support the transition and retention of investigators from mentored career development to research independence. Fogarty is participating. See the table of NIH Institute or Center contacts for additional guidance.

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

• Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) (RFA-AI-19-072)
  AIDS Application Due Date: April 1, 2020
• Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional) (RFA-MH-20-330) and (R21 Clinical Trial Not Allowed) (RFA-MH-20-331)
  AIDS Application Due Date: March 11, 2020.
• Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) (PAR-20-078)
  Application Receipt Date(s): February 26, 2020, October 28, 2020 and more
• Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) (RFA-AG-21-010)
  Application Receipt Date(s): June 17, 2020
• Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional) (RFA-DK-19-029)
  Application Receipt Date(s): April 7, 2020
• Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) (PAR-20-055) and (R21 Clinical Trials Not Allowed) (PAR-20-082)
  Application Receipt Date(s): Standard dates apply
• BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) (RFA-NS-20-006)
  Application Receipt Date(s): March 24, 2020, June 2, 2020, October 1, 2020 and more
• Physiologically-based pharmacokinetic/pharmacodynamic model extrapolation to human from rabbit for ophthalmic drug products (U01) Clinical Trials Not Allowed (RFA-FD-20-018)
• Bioequivalence of Topical Products: Elucidating Fundamental Principles of Dermal Pharmacokinetics for Microdialysis or Microperfusion Techniques (U01) Clinical Trials Not Allowed (RFA-FD-20-019)
  Application Receipt Date(s): February 27, 2020
• Improving Management of Opioids and Opioid Use Disorder (OUD) in Older Adults (R18) (RFA-HS-20-001)
  Application Receipt Date(s): February 23, 2020
  Note: Foreign institutions may participate in projects as members of consortia or as subcontractors.

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

• The PHI/CDC Global Health Fellowship Program, implemented for CDC by the Public Health Institute and its partner Consortium of Universities for Global Health, is a CDC-funded program that offers recent global public health graduates from Council on Education in Public Health accredited schools and programs the opportunity to participate in yearlong fellowships with guidance from leading global health experts from the CDC.
  Application deadline: January 22, 2020
• Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) from the African Academy of Sciences (AAS) supports interdisciplinary and multidisciplinary scientific programs focused on social and sustainable development and health.
  Application deadline: February 28, 2020

Featured Fogarty News and Information

• Readers and editors of the Fogartys Global Health Matters newsletter identified these stories as the top global health research stories of 2019 from Fogarty and NIH

• View all Fogarty news

• View and subscribe to Fogarty's Global Health Matters e-newsletter